
Tirzepatide 60mg
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied for its effects on incretin signaling, glucose-dependent insulinotropic pathways, and metabolic regulation. For laboratory research use only — not for human consumption.
- ≥99% purity, HPLC / MS verified
- Certificate of analysis on request
- Made & shipped in the USA
- Ships same business day if paid before 12PM PST (Mon–Fri)
- Discreet, temperature-safe packaging with tracking
- Free shipping on orders over $300
Specifications & Documentation
| Compound | Tirzepatide |
|---|---|
| Strength | 60mg |
| Molecular Formula | C |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC / MS verified) |
| Grade | Research use only |
You may also like
AOD-9604 + CJC-1295 + Ipamorelin$120.00
AOD 9604, 5mg$80.00
BPC-157, 15mg$140.00
Cagrilintide 5mg$120.00
CJC-1295 Acetate + Ipamorelin Acetate$140.00
CJC-1295 Acetate with DAC, 5mg$100.00
DSIP, 5mg$100.00
Epitalon, 10mg$100.00
GHK-CU, 50mg$100.00
GLOW$140.00
Glutathione 600mg$120.00
IGF-1 LR3, 0.1mg$200.00
IPAMORELIN Acetate, 10mg$70.00
Kisspeptin-10 5mg$70.00
KLOW$260.00
MOTS-c, 40mg$200.00
NAD+, 750mg$180.00
Oxytocin 10mg$70.00
Retatrutide, 20mg$260.00
Retatrutide, 60mg$580.00
Selank 10mg$70.00
Selank + Semax$120.00
Semaglutide, 20mg$210.00
Semaglutide, 3mg$60.00
Semaglutide, 6mg$110.00
Semax 10mg$70.00
SS-31, 50mg$165.00
Tesamorelin Acetate, 5mg$100.00
Tesamorelin + CJC-1295 + Ipamorelin$155.00
Thymosin alpha-1 10mg$100.00
Thymosin Beta-4 Acetate, 15mg$125.00
Thymosin Beta-4 Fragmented, 10mg$100.00
Tirzepatide, 10mg$100.00
Tirzepatide, 30mg$240.00
Wolverine$200.00Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Its structure is based on the native GIP sequence with modifications — including a C20 fatty diacid moiety attached via a linker — that extend half-life and confer activity at both incretin receptors.
In published research, tirzepatide has been investigated for its unique pharmacological profile as the first characterized dual GIP/GLP-1 receptor agonist. Studies have examined its effects on incretin signaling cascades, pancreatic beta-cell function, glucose homeostasis pathways, gastric motility, and central appetite-regulating circuits. Its dual mechanism distinguishes it from single-receptor GLP-1 agonists studied previously in the literature.
Research areas exploring tirzepatide include:
- Incretin receptor pharmacology and signaling
- Glucose-dependent insulinotropic mechanisms
- Energy balance and metabolic regulation models
- Comparative studies with single-agonist GLP-1 analogs
- Receptor binding, internalization, and downstream signaling
- Peptide pharmacokinetics and fatty acid conjugation chemistry
Product Specifications
- Peptide: Tirzepatide
- Quantity: 60mg per vial
- Type: Dual GIP/GLP-1 receptor agonist
- Amino acid length: 39 residues
- Modification: C20 fatty diacid via γGlu-2xOEG linker at Lys20
- Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight: ~4813.5 g/mol
- Purity: ≥98% (HPLC verified)
- Form: Lyophilized powder
- Storage: Store at -20°C, protect from light and moisture; reconstituted solutions refrigerated
Disclaimer: This product is intended for laboratory and research purposes only. It is not a drug, food, or cosmetic, and is not intended for human or animal consumption, diagnostic use, or therapeutic application. This product is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.
